RaySearch Laboratories AB (CHIX:RAYBS) Tariff Resilience Score: 5/10 (As of Jul. 07, 2026)


CHIX:RAYBS RaySearch Laboratories AB CHIX:RAYBS
95 GF Score
Price kr215.50
GF Value kr180.42
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB Tariff Resilience Score?

RaySearch Laboratories AB CHIX:RAYBS 95 Tariff Resilience Score is 5 as of Jul. 07, 2026. GuruFocus rates CHIX:RAYBS with a GF Score™ of 95/100 and a GF Value™ of kr180.42 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 672 Healthcare Providers & Services companies, RaySearch Laboratories AB ranks better than 79.32% on this metric.

RaySearch Laboratories AB has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

RaySearch Laboratories AB has Medical technology company with global sales. Manufacturing in Sweden exposes it to EU tariffs. Historical impacts from US-China trade tensions. Mitigation through diverse markets and alternative suppliers.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes RaySearch Laboratories AB might have Average Resilient.

RaySearch Laboratories AB  (CHIX:RAYBs) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

RaySearch Laboratories AB Tariff Resilience Score Related Terms

CHIX:RAYBS vs VEEV, BTSG, TEM: Tariff Resilience Score Comparison

For the Health Information Services subindustry, RaySearch Laboratories AB's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RaySearch Laboratories AB Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Tariff Resilience Score falls into.


CHIX:RAYBS
95GF Score
RaySearch Laboratories AB CHIX:RAYBS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
RaySearch Laboratories AB (CHIX:RAYBS) has a Tariff Resilience Score of 5 as of Jul. 07, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, RaySearch Laboratories AB ranks #139 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 20.7%.
Is RaySearch Laboratories AB's Tariff Resilience Score too high?
RaySearch Laboratories AB's current Tariff Resilience Score is 5. Based on the distribution chart, RaySearch Laboratories AB ranks #139 out of 672 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, RaySearch Laboratories AB has a GF Score™ of 95/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Tariff Resilience Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, RaySearch Laboratories AB ranks #139 out of 672 companies for Tariff Resilience Score. This places RaySearch Laboratories AB in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. RaySearch Laboratories AB's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (CHIX:RAYBS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr180.42, compared to a current price of kr215.50 — trading 19.4% above its estimated fair value. The current Tariff Resilience Score is 5. RaySearch Laboratories AB's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For RaySearch Laboratories AB (CHIX:RAYBS), the current Tariff Resilience Score is 5 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RaySearch Laboratories AB (CHIX:RAYBS) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued. The current stock price of kr215.50 is trading 19.4% above its estimated GF Value™ of kr180.42. GuruFocus considers RaySearch Laboratories AB to be Modestly Overvalued.

Key valuation signals for CHIX:RAYBS:

  • Tariff Resilience Score: 5
  • GF Value™: kr180.42 vs. price of kr215.50 (19.4% above fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the CHIX:RAYBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
95GF Score

Get the complete analysis for CHIX:RAYBS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr215.50
Price
kr180.42
GF Value